Momentum Stocks: Xerox Corporation (NYSE:XRX), Bellicum Pharmaceuticals (NASDAQ:BLCM), Vitamin Shoppe (NYSE:VSI), Retractable Technologies (NYSEMKT:RVP), Citigroup Inc. (NYSE:C)

On Tuesday shares of Xerox Corporation (NYSE:XRX) closed at $11.55. Company’s sales growth for last 5 years was 5.20% and EPS growth for next 5 years is recorded as 2.00%. Ursula M. Burns, chairman and chief executive officer of Xerox Corporation (NYSE:XRX) will deliver the 2015 Commencement address to Howard University students, faculty, staff, and guests on Saturday, May 9, at 10 a.m., on the upper quadrangle of the Universitys main campus.

Bellicum Pharmaceuticals, Inc. (NASDAQ:BLCM) in last trading activity decreased -2.38% to close at $22.54. Company weekly performance is -10.20% while its quarterly performance stands at -2.38%. Bellicum Pharmaceuticals, Inc. (NASDAQ:BLCM) is -32.98% away from its 52 week high. On 30 April, Bellicum Pharmaceuticals Inc. (NASDAQ:BLCM) has entered into a license agreement with Leiden University Medical Center, Netherlands, for worldwide rights to develop, manufacture and commercialize high-affinity TCR (T cell receptor) product candidates targeting solid tumors expressing the preferentially-expressed antigen in melanoma, or PRAME.

On last trading day Vitamin Shoppe, Inc. (NYSE:VSI) decreased -0.05% to close at $42.31. Its volatility for the week is 2.56% while volatility for the month is 2.86%. VSI’s sales growth for past 5 years was 12.50% and its EPS growth for past 5 years was 48.20%. Vitamin Shoppe, Inc. (NYSE:VSI) monthly performance is 3.32%. Zacks upgraded shares of Vitamin Shoppe (NYSE:VSI)from a sell rating to a hold rating in a research report sent to investors on 1 May.

Retractable Technologies, Inc. (NYSEMKT:RVP) has 0.10% insider ownership while its institutional ownership stands at 5.50%. In last trading activity company’s stock closed at $4.05. Retractable Technologies Inc. (NYSEMKT:RVP) announced that on April 23 2015 the United States District Court for the Eastern District of Texas Marshall Division entered an Amended Final Judgment in RTI’s suit against Becton Dickinson and Company (“BD”) for antitrust and other claims. The Amended Final Judgment includes: BD attempted to monopolize the safety syringe market, BD committed false advertising under the Lanham Act. and RTI recovers from BD $340524042.00.

On Tuesday shares of Citigroup Inc. (NYSE:C) closed at $53.35. Company’s sales growth for last 5 years was 5.20% and EPS growth for next 5 years is recorded as 25.50%. The Board of Directors of Citigroup Inc. (NYSE:C) declared a quarterly dividend on Citigroup’s common stock of $0.05 per share, payable on May 22, 2015 to stockholders of record on May 11, 2015.

Leave a Reply

Your email address will not be published. Required fields are marked *